Literature DB >> 4123119

Myelin basic protein administration in multiple sclerosis.

B Campbell, P J Vogel, E Fisher, R Lorenz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4123119     DOI： 10.1001/archneur.1973.00490250028003

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  14 in total

Review 1.  Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet.

Authors:  Lawrence Steinman
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

2.  Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis.

Authors:  Francesca Odoardi; Naoto Kawakami; Zhaoxia Li; Chiara Cordiglieri; Kristina Streyl; Mikhail Nosov; Wolfgang E F Klinkert; Joachim W Ellwart; Jan Bauer; Hans Lassmann; Hartmut Wekerle; Alexander Flügel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

3.  IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.

Authors:  Duncheng Wang; Debjani Ghosh; S M Touhidul Islam; Cody D Moorman; Ashton E Thomason; Daniel S Wilkinson; Mark D Mannie
Journal:  J Immunol       Date:  2016-09-12       Impact factor: 5.422

Review 4.  Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  I R Mackay; P R Carnegie; A S Coates
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

5.  Treatment of experimental allergic encephalomyelitis with myelin basic protein: which route is best?

Authors:  S Levine; R Sowinski
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

6.  Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.

Authors:  P Y Paterson; R S Fujinami; E D Day; V A Varitek; M D Pescovitz; J Kelly; L Lorand
Journal:  Trans Am Clin Climatol Assoc       Date:  1978

7.  Suppression and reversal of allergic encephalomyelitis in rhesus monkeys with basic protein and peptides.

Authors:  E H Eylar; J J Jackson; P J Kniskern
Journal:  Neurochem Res       Date:  1979-04       Impact factor: 3.996

8.  Failure of basic protein therapy for multiple sclerosis.

Authors:  R E Gonsette; P Delmotte; L Demonty
Journal:  J Neurol       Date:  1977-08-18       Impact factor: 4.849

Review 9.  Antigen-specific immunotherapy of autoimmune and allergic diseases.

Authors:  Catherine A Sabatos-Peyton; Johan Verhagen; David C Wraith
Journal:  Curr Opin Immunol       Date:  2010-09-17       Impact factor: 7.486

10.  Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease.

Authors:  F Odoardi; N Kawakami; W E F Klinkert; H Wekerle; A Flügel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-13       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.